Alteration of cell cycle in cervical tumor associated with human papillomavirus - Cyclin-dependent kinase inhibitors

Medicine and Dentistry

• Human Papillomavirus Type 16 100%
• S Phase 50%
• Mitosis 50%
• Oncoprotein 50%
• Cyclin E 50%
• Cyclin Dependent Kinase Inhibitor 50%
• Cell Cycle Checkpoint 50%
• Diagnosis 25%
• Neoplasm 25%
• Binding Site 25%
• Wart Virus 25%
• Protein Degradation 25%
• Protein P53 25%
• Cell Cycle 25%
• P21 25%
• Prematurity 25%
• Cyclin D1 25%
• G1/S Transition 25%
• P16 25%
• Mitosis Spindle 25%
• Gene 25%
• G2 Phase Cell Cycle Checkpoint 25%
• Spindle Checkpoint 25%
• Comprehension 25%
• Aptitude 25%
• Instability 25%

Biochemistry, Genetics and Molecular Biology

• Human Papillomavirus Type 16 100%
• Mitosis 50%
• S Phase 50%
• Cyclin-Dependent Kinase 50%
• Cyclin E 50%
• E2F 50%
• Cell Cycle Checkpoint 50%
• Nested Gene 25%
• Binding Site 25%
• P53 25%
• Protein Catabolism 25%
• Cell Cycle 25%
• Spindle Checkpoint 25%
• P16 25%
• P21 25%
• Wart Virus 25%
• Cyclin D1 25%
• Mitosis Spindle 25%
• G1/S Transition 25%
• G2 Phase Cell Cycle Checkpoint 25%
• Aptitude 25%
• Comprehension 25%
• Genetics 25%
• Protein Hydrolysis 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Human Papillomavirus Type 16 100%
• Oncoprotein 50%
• Cyclin Dependent Kinase Inhibitor 50%
• Cyclin E 50%
• Neoplasm 25%
• Binding Site 25%
• Prematurity 25%
• Cyclin D1 25%
• Protein P53 25%
• Human Papillomavirus 25%